West Pharmaceutical Services, Inc.
DE ˙ DB ˙ GB00BLGXWY71
266,50 € ↓ -2,60 (-0,97%)
2026-06-03
AKTIENPREIS
SecurityDE:WPS / West Pharmaceutical Services, Inc.
InstitutionCwm, Llc
Latest Disclosed Ownership5,241 shares
Latest Disclosed Value $ 1,313,611
Cwm, Llc reports 71.25% decrease in ownership of WPS / West Pharmaceutical Services, Inc.

On May 14, 2026 - Cwm, Llc filed a 13F-HR form disclosing ownership of 5,241 shares of West Pharmaceutical Services, Inc. (DE:WPS) valued at $1,118,954 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 18,230 shares of West Pharmaceutical Services, Inc.. This represents a change in shares of -71.25% during the quarter. The current value of the position is $1,396,726 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,241 -12,989 -71.25 1,314 26,160.00 0.0034
2026-01-26 2025-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 18,230 1,101 6.43 5 25.00 0.0136
2025-10-15 2025-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 17,129 14,789 632.01 4 0.0135
2025-07-25 2025-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,340 862 58.32 1 0.0018
2025-05-01 2025-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,478 26 1.79 0 0.0013
2025-02-04 2024-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,452 18 1.26 0 0.0020
2024-10-08 2024-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,434 -121 -7.78 0 0.0018
2024-07-10 2024-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,555 -168 -9.75 1 0.0024
2024-04-05 2024-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,723 133 8.36 1 0.0033
2024-02-01 2023-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,590 -24 -1.49 1 0.0030
2023-10-11 2023-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,614 83 5.42 1 0.0037
2023-08-03 2023-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,531 78 5.37 1 0.0036
2023-05-01 2023-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,453 10 0.69 1 0.0034
2023-02-01 2022-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,443 161 12.56 0 -100.00 0.0025
2022-10-27 2022-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,282 127 11.00 315 -9.74 0.0025
2022-07-28 2022-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,155 -363 -23.91 349 -43.98 0.0027
2022-04-21 2022-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,518 453 42.54 623 24.85 0.0044
2022-01-31 2021-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,065 741 228.70 499 330.17 0.0035
2021-09-15 2021-06-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 324 0 0.00 116 0.00 0.0009
2021-07-29 2021-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 324 0 116 0.0009
2021-09-15 2021-03-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 324 0 0.00 116 0.00 0.0009
2021-04-27 2021-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 274 -50 77 0.0007
2021-09-15 2020-12-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 324 0 0.00 116 0.00 0.0009
2021-01-27 2020-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 159 -165 45 0.0004
2021-09-15 2020-09-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 324 0 0.00 116 0.00 0.0009
2020-10-19 2020-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 182 -142 50 0.0006
2021-09-15 2020-06-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 324 0 0.00 116 0.00 0.0009
2020-07-22 2020-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 130 -194 30 0.0004
2021-09-15 2020-03-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 324 0 0.00 116 0.00 0.0009
2020-04-28 2020-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 126 -198 19 0.0003
2021-09-14 2019-12-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 324 0 0.00 116 0.00 0.0009
2020-01-27 2019-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 228 -96 34 0.0004
2021-09-14 2019-09-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 324 0 0.00 116 0.00 0.0009
2019-10-22 2019-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 218 -106 31 0.0005
2021-09-14 2019-06-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 324 0 0.00 116 0.00 0.0009
2019-07-31 2019-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 218 -106 27 0.0004
2021-09-02 2019-03-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 324 105 47.95 116 452.38 0.0009
2019-04-22 2019-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 218 -1 24 0.0005
2019-01-25 2018-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 219 110 100.92 21 61.54 0.0005
2018-10-29 2018-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 109 16 17.20 13 44.44 0.0003
2018-07-31 2018-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 93 83 830.00 9 800.00 0.0003
2018-04-26 2018-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 10 0 0.00 1 0.00 0.0000
2018-01-16 2017-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 10 -45 -81.82 1 -80.00 0.0000
2017-10-16 2017-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 55 0 0.00 5 0.00 0.0002
2017-07-17 2017-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 55 0 0.00 5 25.00 0.0003
2017-04-17 2017-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 55 10 22.22 4 0.00 0.0002
2017-01-19 2016-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 45 45 4 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.